Abstract
Assessing the degree of liver fibrosis in patientswith chronic liver disease assists in management decisions and in determining prognosis. Given that liver biopsy is invasive and carries risks, there is much interest in less invasive technologies to stage liver disease.
Original language | English |
---|---|
Pages (from-to) | 65 - 67 |
Number of pages | 3 |
Journal | Medicine Today |
Volume | 15 |
Issue number | 4 |
Publication status | Published - 2014 |